BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10492038)

  • 1. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes.
    Miranda RN; Briggs RC; Shults K; Kinney MC; Jensen RA; Cousar JB
    Hum Pathol; 1999 Sep; 30(9):1040-9. PubMed ID: 10492038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines.
    Briggs RC; Kao WY; Dworkin LL; Briggs JA; Dessypris EN; Clark J
    J Cell Biochem; 1994 Dec; 56(4):559-67. PubMed ID: 7890814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
    Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients.
    Bellos F; Alpermann T; Gouberman E; Haferlach C; Schnittger S; Haferlach T; Kern W
    Cytometry B Clin Cytom; 2012 Sep; 82(5):295-304. PubMed ID: 22508616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
    Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
    Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias.
    Cousar JB; Briggs RC
    Leuk Res; 1990; 14(10):915-20. PubMed ID: 2259228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic lineage.
    Briggs R; Dworkin L; Briggs J; Dessypris E; Stein J; Stein G; Lian J
    J Cell Biochem; 1994 Feb; 54(2):198-206. PubMed ID: 8175894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.
    Delia D; Aiello A; Soligo D; Fontanella E; Melani C; Pezzella F; Pierotti MA; Della Porta G
    Blood; 1992 Mar; 79(5):1291-8. PubMed ID: 1536952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
    Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
    Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Positivity in Primary Follicles: Potential Pitfall in the Differential Diagnosis With Marginal Zone Lymphoma.
    Manohar V; Peerani R; Tan B; Gratzinger D; Natkunam Y
    Appl Immunohistochem Mol Morphol; 2020; 28(5):384-388. PubMed ID: 30640752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells.
    Bottardi S; Guieze R; Bourgoin V; Fotouhi-Ardakani N; Dougé A; Darracq A; Lakehal YA; Berger MG; Mollica L; Bay JO; Omichinski JG; Milot E
    Exp Hematol; 2020 Aug; 88():68-82.e5. PubMed ID: 32682001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.
    Wang Z; Cook JR
    Am J Clin Pathol; 2019 Feb; 151(3):337-343. PubMed ID: 30346478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow.
    McClintock-Treep SA; Briggs RC; Shults KE; Flye-Blakemore LA; Mosse CA; Jagasia MH; Shinar AA; Dupont WD; Stelzer GT; Head DR
    Am J Clin Pathol; 2011 Mar; 135(3):380-5. PubMed ID: 21350091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.